相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
Elena Dozio et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress
Elena Dozio et al.
BIOMEDICINES (2021)
The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study
Adam Shardlow et al.
PLOS MEDICINE (2020)
Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
Junko Yabuuchi et al.
SCIENTIFIC REPORTS (2020)
Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
Elena Dozio et al.
BIOMEDICINES (2020)
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD
Simone Vettoretti et al.
NUTRIENTS (2019)
Methylglyoxal as a prognostic factor in patients with chronic kidney disease
Yuta Tezuka et al.
NEPHROLOGY (2019)
Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
Ian H. de Boer et al.
DIABETES CARE (2018)
The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)
Tae Nyun Kim et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Advanced glycation end products in the pathogenesis of chronic kidney disease
Naila Rabbani et al.
KIDNEY INTERNATIONAL (2018)
Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant
Jesus Calvino et al.
PLOS ONE (2018)
Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2018)
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
Tomasz W. Kaminski et al.
BMC NEPHROLOGY (2017)
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
Alexis Guerin-Dubourg et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Uremic Toxicity of Advanced Glycation End Products in CKD
Andrea E. M. Stinghen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Oxidant Mechanisms in Renal Injury and Disease
Brian B. Ratliff et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism
Gudrun Caspar-Bell et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease
Alejandra Guillermina Miranda-Diaz et al.
JOURNAL OF DIABETES RESEARCH (2016)
Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study
Mariana Lazo et al.
AMERICAN HEART JOURNAL (2015)
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study
Casey M. Rebholz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
S100/Calgranulin- Mediated Inflammation Accelerates Left Ventricular Hypertrophy and Aortic Valve Sclerosis in Chronic Kidney Disease in a Receptor for Advanced Glycation End Products-Dependent Manner
Ling Yan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression
Marita Liebisch et al.
KIDNEY INTERNATIONAL (2014)
Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
Keiko Fujisawa et al.
ATHEROSCLEROSIS (2013)
Skin Autofluorescence Is Associated with the Progression of Chronic Kidney Disease: A Prospective Observational Study
Kenichi Tanaka et al.
PLOS ONE (2013)
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis
Jwa-Kyung Kim et al.
ATHEROSCLEROSIS (2012)
Reduced soluble receptor for advanced glycation end-products in COPD
D. J. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-Year Follow-Up Study
Johanna W. M. Nin et al.
DIABETES (2010)
RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
Alexey Aleshin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production
Sohachi Fujimoto et al.
HYPERTENSION RESEARCH (2008)
Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (-/-) mice and improved by combined administration of L-arginine and antioxidants
Monica G. Arellano Mendoza et al.
NEPHROLOGY (2008)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Soluble receptor for advanced glycation end products in patients with decreased renal function
M Kalousová et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
D Geroldi et al.
JOURNAL OF HYPERTENSION (2005)
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men
C Falcone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study
P Muntner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease
BP Oberg et al.
KIDNEY INTERNATIONAL (2004)
Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing?
C Schlueter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Central role of RAGE-dependent neointimal expansion in arterial restenosis
T Sakaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Cardiac performance and morphology in end-stage renal disease
MA Alpert
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2003)
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
T Shimoike et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
分享论文
